<?xml version="1.0" encoding="UTF-8"?><add><doc><field name="id">0008688</field><field name="title">[GENE] SAYS FDA TO REVIEW TPA</field><field name="place">SOUTH SAN FRANCISCO</field><field name="date">April 1</field><field name="content">- Genentech Inc said Activase, its tissue plasminogen activator, will be reviewed at the a regularly scheduled May 29 meeting of the Food and Drug Administration's cardiorenal advisory committee. </field></doc></add>